• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Abnormal cytogenetic clones in patients with aplastic anaemia: response to immunosuppressive therapy.

作者信息

Geary C G, Harrison C J, Philpott N J, Hows J M, Gordon-Smith E C, Marsh J C

机构信息

Department of Haematology, Manchester Royal Infirmary, London.

出版信息

Br J Haematol. 1999 Feb;104(2):271-4. doi: 10.1046/j.1365-2141.1999.01187.x.

DOI:10.1046/j.1365-2141.1999.01187.x
PMID:10050707
Abstract

We report the response to immunosuppressive therapy with antithymocyte globulin (ATG) and cyclosporin or oxymetholone in 13 cases of aplastic anaemia (AA) with an abnormal cytogenetic clone detected at or sometime after diagnosis. Blood and bone marrow examination showed no distinctive morphological features of myelodysplasia (MDS) at diagnosis. Haematological response occurred promptly in eight cases; the remainder responded after additional immunosuppression with or without oxymetholone. Three patients had a late relapse of AA, treated successfully by allogeneic bone marrow transplantation in one; the others responded to oxymetholone. Transformation to MDS or acute leukaemia was not observed after a median follow-up of 4.1 years (range 1.2-11.2). In four patients the cytogenetic clone disappeared after treatment.

摘要

相似文献

1
Abnormal cytogenetic clones in patients with aplastic anaemia: response to immunosuppressive therapy.
Br J Haematol. 1999 Feb;104(2):271-4. doi: 10.1046/j.1365-2141.1999.01187.x.
2
Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone.再生障碍性贫血的免疫抑制治疗:抗胸腺细胞球蛋白(ATG)、甲泼尼龙和羟甲烯龙与ATG、超高剂量甲泼尼龙和羟甲烯龙的前瞻性随机试验结果。
Blood. 1992 May 15;79(10):2566-71.
3
A patient with non-A, non-B, non-C hepatitis-associated aplastic anemia recovered promptly following immuno-suppressive therapy, including antithymocyte globulin.一名患有非甲、非乙、非丙型肝炎相关性再生障碍性贫血的患者在接受包括抗胸腺细胞球蛋白在内的免疫抑制治疗后迅速康复。
Int J Hematol. 1998 Jun;67(4):403-9. doi: 10.1016/s0925-5710(98)00017-6.
4
Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation.成人重型再生障碍性贫血的治疗:抗胸腺细胞球蛋白(ATG)作为初始治疗及骨髓移植挽救ATG治疗失败的患者
Am J Med. 1992 Jun;92(6):596-602. doi: 10.1016/0002-9343(92)90776-8.
5
Antilymphocyte globulin (ALG) or antithymocyte globulin (ATG) with methylprednisone and oxymethalone in aplastic anaemia.抗淋巴细胞球蛋白(ALG)或抗胸腺细胞球蛋白(ATG)联合甲泼尼龙和羟甲烯龙治疗再生障碍性贫血。
J Assoc Physicians India. 1997 Apr;45(4):263-6.
6
[Results of immunosupressive therapy in children with severe aplastic anaemia. Report of the Polish Paediatric Haematology Group].[重症再生障碍性贫血患儿免疫抑制治疗的结果。波兰儿科学血液学组报告]
Med Wieku Rozwoj. 2008 Oct-Dec;12(4 Pt 2):1092-7.
7
Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens.
Exp Hematol. 1987 Mar;15(3):239-42.
8
Diagnosis and treatment of acquired aplastic anaemia in adults: 142 cases from a multicentre, prospective cohort study in Shanghai, China.成人获得性再生障碍性贫血的诊断与治疗:来自中国上海一项多中心前瞻性队列研究的142例病例
J Int Med Res. 2011;39(5):1994-2005. doi: 10.1177/147323001103900546.
9
Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.一项试点研究,使用他克莫司而非环孢素加抗胸腺细胞球蛋白作为成人重型再生障碍性贫血免疫抑制治疗方案的选择。
Blood Cells Mol Dis. 2014 Sep;53(3):157-60. doi: 10.1016/j.bcmd.2014.04.008. Epub 2014 Jun 13.
10
Acquired aplastic anaemia: still a serious disease.获得性再生障碍性贫血:仍然是一种严重的疾病。
Arch Dis Child. 1991 Jul;66(7):858-61. doi: 10.1136/adc.66.7.858.

引用本文的文献

1
Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition.成人原发性免疫性血小板减少症诊断参考指南,2023 年版。
Int J Hematol. 2024 Jan;119(1):1-13. doi: 10.1007/s12185-023-03672-1. Epub 2023 Nov 13.
2
Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia.免疫抑制治疗后重型再生障碍性贫血患者克隆演变和髓系肿瘤的预测因素。
Leukemia. 2022 Sep;36(9):2328-2337. doi: 10.1038/s41375-022-01636-8. Epub 2022 Jul 27.
3
Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.
获得性再生障碍性贫血和阵发性睡眠性血红蛋白尿症中的继发性骨髓增生异常综合征和白血病。
Blood. 2020 Jul 2;136(1):36-49. doi: 10.1182/blood.2019000940.
4
Risk factors associated with poor response to immunosuppressive therapy in acquired aplastic anemia: A meta-analysis of retrospective studies.获得性再生障碍性贫血中免疫抑制治疗反应不佳的相关危险因素:一项回顾性研究的荟萃分析
Exp Ther Med. 2020 Apr;19(4):3104-3112. doi: 10.3892/etm.2020.8536. Epub 2020 Feb 19.
5
Cytogenetic study is not essential in patients with aplastic anemia.对于再生障碍性贫血患者,细胞遗传学研究并非必不可少。
Am J Blood Res. 2017 Nov 1;7(5):49-58. eCollection 2017.
6
Cytogenetic profile of aplastic anaemia in Indian children.再生障碍性贫血患儿的细胞遗传学特征。
Indian J Med Res. 2013 Mar;137(3):502-6.
7
Incidence and clinical characteristics of clonal cytogenetic abnormalities of acquired aplastic anemia in adults.成人获得性再生障碍性贫血克隆性细胞遗传学异常的发病率及临床特征
Korean J Hematol. 2010 Dec;45(4):242-6. doi: 10.5045/kjh.2010.45.4.242. Epub 2010 Dec 31.
8
Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions.阿仑单抗治疗中危-1 骨髓增生异常综合征患者可使血细胞计数和细胞遗传学缓解持续改善。
J Clin Oncol. 2010 Dec 10;28(35):5166-73. doi: 10.1200/JCO.2010.29.7010. Epub 2010 Nov 1.
9
Immunosuppression for myelodysplastic syndrome: how bench to bedside to bench research led to success.骨髓增生异常综合征的免疫抑制治疗:从基础到临床再到基础的研究如何取得成功。
Hematol Oncol Clin North Am. 2010 Apr;24(2):331-41. doi: 10.1016/j.hoc.2010.02.009.
10
Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy-systematic review and meta-analysis.接受免疫抑制治疗的再生障碍性贫血患者的造血生长因子——系统评价与荟萃分析
Haematologica. 2009 May;94(5):712-9. doi: 10.3324/haematol.2008.002170. Epub 2009 Mar 31.